Hypertrophic Cardiomyopathy
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
Hypertrophic Cardiomyopathy
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hypertrophic Cardiomyopathy
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
"Hypertrophic cardiomyopathy: two homozygous cases with ""typical"" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy."
|
12951062 |
2003 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
"Hypertrophic cardiomyopathy: two homozygous cases with ""typical"" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy."
|
12951062 |
2003 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
87 patients with HCM and 71 patients with DCM were screened for MYBPC3 mutations by denaturing gradient gel electrophoresis and sequencing.
|
18957093 |
2008 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease and is often a consequence of mutations in the myosin-binding protein C gene (MYBPC3).
|
16566405 |
2005 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric septal hypertrophy and is often caused by mutations in MYBPC3 gene encoding cardiac myosin-binding protein C. In contrast to humans, who are already affected at the heterozygous state, mouse models develop the phenotype mainly at the homozygous state.
|
22076249 |
2012 |
Hypertrophic Cardiomyopathy
|
0.700 |
Biomarker
|
disease |
CTD_human |
Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric septal hypertrophy and is often caused by mutations in MYBPC3 gene encoding cardiac myosin-binding protein C. In contrast to humans, who are already affected at the heterozygous state, mouse models develop the phenotype mainly at the homozygous state.
|
22076249 |
2012 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypertrophic cardiomyopathy genotyping revealed the common C to T substitution at coding nucleotide 1504 of MYBPC3, c1504C>T.
|
27177834 |
2016 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
|
30446606 |
2018 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India.
|
18273486 |
2008 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India.
|
18273486 |
2008 |
Hypertrophic Cardiomyopathy
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India.
|
18273486 |
2008 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Myosin-binding protein C3 (<i>MyBPC3</i>) gene mutations are the most common genetic cause of HCM.
|
28450932 |
2017 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
MYBPC3 and MYH7 mutations contributed to 50.0% and 24.4% of the HCM patients, respectively, suggesting that MYBPC3 mutations were the most frequent cause of HCM in our cohort.
|
29121657 |
2017 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
MYBPC3 mutations have been described in dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM).
|
29493010 |
2018 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
MYBPC3Δ25bp/D389V is associated with hyperdynamic features, which are an early finding in hypertrophic cardiomyopathy and thought to reflect an unfavorable energetic state.
|
29641836 |
2018 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
|
30550750 |
2019 |
Hypertrophic Cardiomyopathy
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
A case of compound mutations in the MYBPC3 gene associated with biventricular hypertrophy and neonatal death.
|
22907696 |
2012 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy.
|
19659763 |
2009 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia.
|
19151713 |
2009 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A custom next-generation sequencing (NGS) technology for the HCM panel allowed us to identify compound heterozygous mutations in the MYBPC3 gene, confirming NGS as a molecular diagnostic tool.
|
30896616 |
2019 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
|
18409188 |
2008 |
Hypertrophic Cardiomyopathy
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
|
18409188 |
2008 |
Hypertrophic Cardiomyopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A founder mutation arising at about the 10th century in the MYBPC3 gene accounts for 8.4% of all HCM in center east France and results in a cardiomyopathy starting late and evolving slowly but with an apparent risk of sudden death similar to other sarcomeric mutations.
|
23140321 |
2012 |